183 results
S-8
EX-23.1
KPRX
Kiora Pharmaceuticals Inc
10 May 24
Registration of securities for employees
6:59am
on Form S-8 of Kiora Pharmaceuticals, Inc. (the “Company”) of our report dated March 25, 2024, relating to our audit of the Company’s consolidated
S-8
EX-23.2
KPRX
Kiora Pharmaceuticals Inc
10 May 24
Registration of securities for employees
6:59am
of Kiora Pharmaceuticals, Inc. on Form S-8 to be filed on or about May 10, 2024 of our report dated March 23, 2023, on our audit of the financial
8-K
EX-10.1
ngmivzv0anxz7r
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-10.1
i9e2m4x8chka8
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
8-K
obc9mwgc
21 Sep 23
Kiora Pharmaceuticals Appoints Praveen Tyle, PhD, as New Chairman; Succeeds Paul Chaney Who is Retiring After Serving 17 Years
7:00am